2023 Future Healthcare Technology Conference Concludes, Paving the Way for a New Era in Medical Innovation

December 1, 2023, marked the second day of the "2023 Future Medical Technology Conference." Hosted by the Hefei Municipal People's Government, the Leading Group Office for the Construction of "Science and Technology Valley," the Working Group for the Promotion of Anhui Province's Life Health Industry, the University of Science and Technology of China, and the Organizing Committee of the Future Medical Technology Conference. Co-hosted by VCBeat, VB100, and VCBeat Think Tank (VBInsight). Undertaken by the Hefei Development and Reform Commission, Hefei Economic and Information Technology Bureau, Hefei Health Commission, Science and Technology Valley Service Platform Company, Global Alumni Affairs Department of Science and Technology Valley, and ITMNS. Supported by the Advanced Medical Device Industry Incubation Alliance of the Chinese Academy of Sciences. The conference spanned two days and attracted participation from over a hundred global biopharmaceutical enterprises.

The supporting units of this conference include Legend Capital, Baidu Ventures, Morningside Ventures, Sherpa Healthcare Partners, GSR Ventures, Proxima Capital, Buchang Pharmaceuticals, MicroCloud Group, MathWorks, Ruissen Medical, MGI, IFLY TEK, Unisound AI Technology Co., Ltd., Beijing Yixiaomiao Technology Co., Ltd., Tianjin Jinxi Medical Equipment Co., Ltd., TowardPi (Beijing) Medical Technology Co.,Ltd, Telefield Medical Imaging Limited, BEIJING TONGHELITAI BIOTECHNOLOGY CO.,LTD, Guangxi Character Zhizao Life Science R & D Co., Ltd., Wuxi Fresh Air Air Quality Technology Co., Ltd., TONGSHU GENE, and other innovative companies and well-known institutions.

Panorama of the Second Day of the Conference

The conference venue was still bustling with people on the second day, vibrant and lively. Influential figures from various sectors of the industry, including government, academia, research, medicine, and investment, shared and discussed two cutting-edge tracks—biotechnology, intelligent manufacturing, and materials—to identify new trends and share new opportunities.

The morning session begins.Fan Xiaohu, Dean of the Institute of Gene and Cell Therapy at Xi'an Jiaotong University, and founder of Legend Biotech and Wan Dao CellDelivered a speech titled "Opportunities and Challenges for China's Original Innovative Drugs in the Era of Cell and Gene Therapy," sharing the arduous journey of Legend Biotech and the latest advancements of Bay Island Cells, stating that the most important technology to potentially change humanity in the next 20 to 30 years could be artificial intelligence or cell and gene therapy.

Director of the Institute of Gene and Cell Therapy at Xi'an Jiaotong University, former Chief Scientific Officer of Legend Biotech,

Speech by Fan Xiaohu, Founder of Bay Island Cells

Professor Wei Hong, former professor of the Basic Medical College of the Third Military Medical University and chairman of the Germ-Free Animal Professional Committee of the Chinese Laboratory Animal AssociationShared the thematic report "CRO Platform for Functional Microbiome Based on Germ-Free Animals," in which he mentioned that microbiome technology is a disruptive technology and will definitely form a large industry in the future, as it involves not only the human body but also animals, plants, and microorganisms themselves. This will bring tremendous impetus to the development of biomedicine.

Professor Wei Hong, Former Professor of the College of Basic Medicine at the Third Military Medical University and Chairman of the Germ-Free Animal Professional Committee of the Chinese Laboratory Animal Society, Delivered a Speech

Yang Maojun, Professor at the School of Life Sciences, Tsinghua University, and Researcher at the Beijing Frontier Research Center for Biological StructuresShared "The Molecular Basis of Breathing: How to Break the Limits of Human Lifespan," stating that human aging is mainly due to the decrease in the efficiency of oxygen utilization by somatic cells as age increases, which is primarily reflected in changes in the number of breaths per minute. For example, infants breathe 30-50 times per minute, adults 16-20 times, and elderly people 14-16 times. Engaging in activities that increase the number of breaths, such as running until out of breath, is beneficial for the body. In addition to using appropriate medications to improve oxygen utilization efficiency, the most economical approach is regular exercise. Exercise not only enhances respiratory function but also strengthens mitochondrial function, thereby reducing inflammation.

Yang Maojun, Professor at the School of Life Sciences, Tsinghua University, and Researcher at the Beijing Frontier Research Center for Biological Structure

Hu Songnian, Chief Engineer of the Chinese part of the Human Genome Project and researcher at the Institute of Microbiology, Chinese Academy of SciencesThe sharing topic he brought is "Prospects for the Development and Application of Genomics Technology." He stated that with the vast amount of genomic data now available, advancements in fields such as biological storage and AI are becoming increasingly intertwined with the development of genomics technology, and the future potential is highly anticipated.

Hu Songnian, Chief Engineer of the Chinese part of the Human Genome Project and researcher at the Institute of Microbiology, Chinese Academy of Sciences, shared

Yang Hui, Founder of Huigene, Chief Scientific Advisor, and Recipient of the National Outstanding Youth FundIn the thematic introduction of "Gene Editing and Gene Therapy," it was noted that gene editing technology has developed rapidly since 2012, and there are already approved drugs on the market. In terms of drug delivery methods, gene editing therapy mainly involves three approaches. Finally, the latest progress and achievements of Huidagene were introduced in detail.

Yang Hui, Founder of Huigene, Chief Scientific Advisor, and Recipient of the National Outstanding Youth Fund, Shares

Founder & Chairman of Lingtek Biotechnology, Chief Scientist of China's National Key R&D Program, Song XuBrought the sharing of "lncRNA Opens Up a New Field for Nucleic Acid Drugs," where he presented part of the research results on the stabilization and delivery of nucleic acid drugs achieved by lncRNA, as well as the latest progress of Lingtaikr Biotechnology, and shared his outlook on the future of the industry.

Lingtaikr Bio Founder & Chairman, Chief Scientist of National Key R&D Program, Song Xu Shares

Liang Hong, Distinguished Professor of Shanghai Jiao Tong UniversityHe shared "General Artificial Intelligence in Protein Engineering," stating that artificial intelligence, especially large models, has completely revolutionized the field of protein engineering. All application scenarios of proteins will benefit, offering unlimited opportunities. Of course, there are still many unknowns to be explored in this field, so it is necessary to move forward with more colleagues.

Liang Hong, Distinguished Professor at Shanghai Jiao Tong University, shared

《Gene Therapy Based on Neuronal In-Situ Transdifferentiation Technology》

Liu Yueguang, Co-founder and Chief Scientific Officer of Neulens, Shares

The afternoon session begins.Zhang Mingjun, Tenured Professor and Doctoral Supervisor at Tsinghua UniversityShared the thematic report "Innovative Research on the Application of Micro-Nano Robots in Drug Delivery and Brain-Computer Interfaces," in which he introduced the definition, progress, and global dynamics of micro-nano robots to the audience. He also mentioned that micro-nano robots provide a novel approach for achieving ultra-minimally invasive brain-computer interfaces with dynamic bidirectional interaction of material flow, energy flow, and information flow.

Zhang Mingjun, Tenured Professor and Doctoral Supervisor at Tsinghua University, Shares

Professor Liu Yanju, Director of the Intelligent Composite Materials Committee of the Chinese Load Material Society, Department of Aerospace Science and Mechanics, School of Astronautics, Harbin Institute of TechnologyShe shared "4D Printing of Intelligent Composite Structures and Their Biological Applications," mentioning that smart materials have broad application prospects not only in aerospace, shipping, traffic engineering, and other fields but also can play a significant role in the biomedical field, thereby bringing benefits to patients and serving humanity.

Professor Liu Yanju, Director of the Intelligent Load Materials Professional Committee of the Chinese Load Materials Society, shared.

Professor Ai Hua, Fellow of the International Union of Biomaterials Science and Engineering, National Engineering Research Center for Biomaterials, Sichuan UniversityIt was mentioned in the sharing that clinical needs are the core driving force behind the research and development of biomaterials. In-depth studies on the relationship between implantable medical devices and surrounding body tissues, attention to the surface/interface issues of materials, consideration of the structural heterogeneity of the tissues being replaced, and the use of imaging methods for long-term observation of the status of implanted devices all play a very important role in the innovation and development of medical devices.

Professor Ai Hua, International Union of Biomaterials Science and Engineering, National Engineering Research Center for Biomaterials, Sichuan University

Professor Wang Shouli, toxicologist and pathologist certified by the U.S. FDA, and Chief Scientist of Bosaif MedicalThe sharing topic is "Suggestions on the Construction of GLP for Preclinical Evaluation Based on Recent Global Medical Device Adverse Event Research." He first introduced typical cases of global medical device adverse events, conducted a detailed analysis, and provided some recommendations. Finally, he expressed expectations for the industry's future development and shared exploration experiences regarding the qualification and system construction of preclinical evaluation institutions for medical devices.

Wang Shouli, Director of the Pathology Center at Soochow University School of Medicine, shared

Chi Bo, Professor at the State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech UniversityIt was mentioned in the sharing that the gel has excellent biocompatibility and can carry different materials, making it very suitable for human tissue repair and organ regeneration. Currently, the clinical application of hydrogels is developing rapidly, but at the same time, the clinical application of hydrogels still faces many difficulties.

Professor Chi Bo from the State Key Laboratory of Materials-Oriented Chemical Engineering at Nanjing Tech University shared

Yang Yuexiong, Part-time Professor of Biomedical Engineering at Sun Yat-sen University and General Manager of Sun Yat-sen University Medical DevicesDelivered a keynote speech titled "Thoughts on the Application of Shenqiao@ in C7 Nerve Transfer Surgery for Central Hemiplegia and AI, EEG," sharing insights from three aspects: an overview of the company, the introduction of Shenqiao and C7 surgery, and the expert team.

Yang Yuexiong, Part-time Professor of Biomedical Engineering at Sun Yat-sen University and General Manager of Sun Yat-sen University Medical Devices, shared

In the final sharing,Nano Vision Liang JunNano Weijing, which has independently developed whole-body medical static CT technology, has significantly improved the temporal resolution and spatial resolution, and can achieve multi-spectral imaging. At the same time, in order to realize the self-research and self-production of static CT, Nano Weijing has successively overcome core components such as array integrated ray sources and photon flow detectors.

Nano Vision Liang Jun Sharing

In addition to the wonderful sharing by big names at the main forum, on the second day of the conference, there were also"Generative AI Scenario Innovation Application Forum"And "2023 FTC 5th Frontier Technology in Cardiovascular Surgery Forum, and conducted more in-depth discussions on细分 technical fields.

The "2023 Future Medical Technology Conference" has successfully concluded, marking the official start of a new journey in medical innovation.